LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,441 pages found matching data breach- Potential Malfunction Lawsuits Filed Against Medtronic
Nov-29-07 Charleston, WV Medtronic faces more lawsuits alleging that its Sprint Fidelis Leads caused injury or death to patients using the leads. And lawsuits have been filed by plaintiffs who argue that the potential for a malfunction causes them a great deal of stress and has negatively impacted their lives. One lawsuit, which seeks class action status, al... - FDA's Refusal to Approve New Cancer Vaccine - The Plot Thickens - Part II
Nov-29-07 Washington, DC: On November 26, 2007, CareToLive, the non-profit corporation that is suing FDA officials on behalf of terminal prostate cancer patients over the decision not to approve Provenge, a new life-extending prostate cancer vaccine, announced that a judge had dismissed the lawsuit. Please click here for a free evaluation of your case The... - Clinical Trail Software, Etrials agrees to pay Datasci a $1.75 million settlement for patent infringement
Raleigh, NC: (Nov-27-07) Datasci LLC brought charges against Etrials, a Morrisville company which provides software to help run clinical trials of drugs and medical devices, alleging that it infringed on its patents. Sources claimed that the Datasci case is a chink in the patent system, in which the US Patent & Trademark Office in 2002 essentially granted... - Possible Myfortic Pregnancy Risks Lawsuit
Novartis and the FDA informed healthcare professionals and patients that use of Myfortic Delayed-Release Tablets during pregnancy is associated with increased risks of pregnancy loss and congenital malformations. The pregnancy category for Myfortic has been changed to Category D (positive evidence of fetal risk). This change is a result of post marketing d... - Salary Structure, City of Peoria pays over $2 million for breaching previous settlement terms
Peoria, IL: (Nov-26-07) A trio of appellate judges in Ottawa alleged that the City Hall didn't follow through on a nearly decade-old settlement with several dozen women over unequal pay. Sources stated that the outcome of the ruling could set the city back several million. Court documents showed that the 3rd District Appellate Court, in its eight-page orde... - FDA's Refusal to Approve New Cancer Vaccine - The Plot Thickens - Part I
Nov-27-07 Washington, DC: Dying prostate cancer patients waiting for the approval of Provenge, a new life-extending cancer vaccine, are being held hostage by an FDA infested with industry insiders with enormous financial interests in what has become a multibillion dollar cancer treatment racket for drug companies, cancer researchers, and treatment providers alike. ... - Burn Injury Victims Can File Lawsuits
Nov-26-07 Buffalo, NY A burn injury is an incredibly painful, usually accidental injury that can dramatically alter a person's life. In many cases, the event which caused the burn injury was the result of actions on the part of someone other than the victim. If those actions were negligent or otherwise unlawful, the injured person can file a lawsuit. If the inju... - Spin Doctor: Behind the Scenes of Drug Detailing
Nov-26-07 Newburyport, MA It's called the drug lunch, and it has nothing to do with hippies rolling a few joints and toking up during their mid-day meal break. Rather, the drug lunch appears to be a valued marketing tool for the big pharma drug companies, where doctors are paid to talk to other doctors and the medical community at large, about drug products. It's... - Burst.com iPod Patent, Apple Inc. agrees to pay $10 million patent infringement settlement
San Francisco, CA: (Nov-21-07) Burst.com brought a patent infringement lawsuit against Apple Inc., alleging that it infringed patents that the two companies agreed to share. The lawsuit, filed in 2004, claimed that some of Burst.com's media patents formed the basis of the iPod. Apple launched a preemptive lawsuit against Burst in the District Court of Nort... - Lawmakers Warn Drug Makers To Knock It Off After Avandia Debacle - Part II
Nov-22-07 Washington, DC: On November 14, 2007, the FDA added a new black box warning to GlaxoSmithKline's diabetes drug Avandia , about a potential increased risk of heart attacks, in addition to the black box warning that was added in August 2007, about the increased risk of heart failure. The FDA said the new warning would also apply to Glaxo's diabetes drugs... - Lawmakers Warn Drug Makers To Knock It Off After Avandia Debacle - Part I
Nov-20-07 Washington, DC: On November 15, 2007, the ranking Republican member of the Senate Finance Committee, Senator Charles Grassley, sent a not-so-subtle warning to the pharmaceutical industry when he invited scientists to contact his office if a company threatens their career or attacks their reputation when they raise alarm about a possibly dangerous drug. ... - Nexium's European Patent Upheld
Nov-20-07 Albuquerque, NM: The European Patent Office (EPO) has ruled that AstraZeneca's European patent covering the MUPS formulation, (EP 723 437), is still valid. MUPS® stands for multiple unit pellet tablets, comprising a proton pump inhibitor (PPI) compound. The MUPS formulation is used for both Nexium and Losec. The ruling is significant because Nexium is... - Apartment Mold, Landlord Roosevelt Owyang agrees to pay 12 families $1.3 million settlement
Oakland, CA: (Nov-18-07) Twelve immigrant families who lived in a dilapidated, unheated, mold and cockroach infested apartment, brought charges against their landlord, Roosevelt Owyang, accusing him of not providing a habitable dwelling at the complex. The suit also alleged breach of contract. The former tenants stated that rain water leaked into their apa... - Avandia Maker Tried to Silence Critic, Feds Allege
Nov-19-07 Washington, DC A noted physician who has been warning about the dangerous side effects of Avandia since 1999, and who was the target of alleged intimidation by Avandia manufacturer GlaxoSmithKline (Glaxo) (GSK), was vindicated Thursday by the US Senate Finance Committee. Operating within its jurisdiction over Medicare and Medicaid, the government comm... - Avandia: A New Black Box Warning, and a Reprieve from the FDA
Nov-18-07 Washington, DC As some had predicted, GlaxoSmithKline caved to sustained pressure by the US Food and Drug Administration (FDA) and agreed to add a second black box warning for Avandia , the diabetes drug linked to increased risk of heart attack. However, the warning is somewhat watered-down, and in the absence of any unforeseen, blockbuster medical r... - Trasylol: The FDA and Bayer AG Wait, while 4.8 Million Patients Wonder...
Nov-18-07 Washington, DC By the time Bayer AG caved to pressure from regulators and pulled Trasylol from the global marketplace earlier this month, an estimated 4.8 million cardiac patients had received the suspended drug since it was first introduced in 1993. Many of those patients, having experienced kidney failure, stroke or heart problems since receiving Tra... - Fuel Efficient Contract, Dana Corp. agrees to pay Permo-Drive Technologies $1.3 million breach of contract settlement
New York, NY: (Nov-15-07) Australia's Permo-Drive Technologies Ltd. brought charges against Dana Corp., over a dispute that stemmed from an aborted plan to develop fuel efficient technology for US military vehicles like the Humvee. Records state that Toledo, Ohio-based Dana has been in Chapter 11 reorganization since March 2006 and aims to exit bankruptcy... - Medtronic Sprint Fidelis Leads Facing More Lawsuits
Nov-15-07 Minneapolis, MN More lawsuits have been filed against Medtronic related to its defective Sprint Fidelis leads. Two Kansas residents have filed class action lawsuits alleging that Medtronic was negligent in the design of its Sprint Fidelis Leads. Both lawsuits also allege that Medtronic failed to warn patients about the possible defects in a timely manner... - Zyprexa: Highest Rate of Suicides in its Class
Nov-15-07 Houston, TX A drug prescribed to combat agitation, has the potential to cause agitation: such is the disconnect often found in the drug world and in this case Zyprexa , which has been linked to several serious side effects including diabetes and stroke, and has generated much lawsuit activity. Most damning of all, is the reality that a drug which is... - Possible Maxipime Risk of Death Lawsuit
The FDA issued an early communication about the ongoing review of new safety data and the request for additional data to further evaluate the risk of death in patients treated with Cefepime. An article in the May 2007 issue of The Lancet Infectious Diseases (Efficacy and safety of Cefepime: a systematic review and meta analysis) raised the question about i...